Mresvia Dosage
Generic name: RNA-100-AR02 50ug in 0.5mL
Dosage form: injection
Drug class: Viral vaccines
Medically reviewed by Drugs.com. Last updated on Dec 16, 2024.
Preparation for Administration
MRESVIA is supplied as a pre-filled syringe that contains a frozen suspension that must be thawed prior to administration.
Thaw each syringe before use, either in the refrigerator or at room temperature, following the instructions in Table 1.
| Configuration | Thaw in Refrigerator | Thaw at Room Temperature |
|---|---|---|
|
Carton of 1 pre-filled syringe in a blister pack |
Thaw between 2°C to 8°C (36°F to 46°F) for 100 minutes. Let each pre-filled syringe stand at room temperature for between 10 and 20 minutes before administering the vaccine. |
Thaw between 15°C to 25°C (59°F to 77°F) for 40 minutes. If MRESVIA is thawed at room temperature, the vaccine is ready to be administered. |
|
Carton of 2 pre-filled syringes in a blister pack |
Thaw between 2°C to 8°C (36°F to 46°F) for 100 minutes. Let each pre-filled syringe stand at room temperature for between 10 and 20 minutes before administering the vaccine. |
Thaw between 15°C to 25°C (59°F to 77°F) for 40 minutes. If MRESVIA is thawed at room temperature, the vaccine is ready to be administered. |
|
Carton of 10 pre-filled syringes in blister packs |
Thaw between 2°C to 8°C (36°F to 46°F) for 160 minutes. Let each pre-filled syringe stand at room temperature for between 10 and 20 minutes before administering the vaccine. |
Thaw between 15°C to 25°C (59°F to 77°F) for 80 minutes. If MRESVIA is thawed at room temperature, the vaccine is ready to be administered. |
- •
- After thawing, do not refreeze.
- •
- Do not shake. Syringes should not be returned to the refrigerator after standing at room temperature.
- •
- Pre-filled syringes may be stored at 8°C to 25°C (46°F to 77°F) for a total of 24 hours after removal from refrigerated conditions. Discard the thawed pre-filled syringe if not used within this time.
- •
- Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
- •
- MRESVIA is a white to off-white suspension that may contain visible white or translucent product-related particulates. Do not administer if the vaccine is discolored or contains other particulate matter.
More about mRESVIA (rsv vaccine, mrna)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Patient resources
Professional resources
Related treatment guides
See also:
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Beyfortus
Beyfortus is used to protect babies under 1 year of age from serious RSV lung infections. A ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Palivizumab
Palivizumab systemic is used for RSV, RSV Vaccination and Immunization
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
